Thryv Therapeutics licenses new class of SGK1 inhibitors, expanding into neurodegenerative disease

Sensorion secures French approval for Phase I/II SENS-601 hearing-loss trial

Foventa makes key CMO and CFO appointments

Akeso's ivonescimab meets overall survival endpoint in interim analysis of Phase III HARMONi-2 study

Teva reports positive Phase 2a data for TEV '408 in celiac disease

Ono Pharma partners with Aitia on neurological disease drug discovery

BioMarin completes Alesta Therapeutics acquisition

BioViva receives US patent for Klotho gene therapy targeting age-related cognitive decline

AstraZeneca completes global licence agreement for Zegfrovy

AstraZeneca and Daiichi Sankyo's Enhertu plus pertuzumab approved in EU for first-line HER2-positive metastatic breast cancer

NeuroSense reveals strategy to advance PrimeC toward potential ALS approval

UCB agrees with US government to lower medicine costs and strengthen US manufacturing

BioArctic and Eisai announce final positive recommendation from Canada's Drug Agency supporting public reimbursement of Leqembi

Karyopharm seeks accelerated FDA approval for selinexor–ruxolitinib in myelofibrosis

Lilly to acquire Merida Biosciences in USD2.875bn deal